alexa Safety and cost-effectiveness of acitrom for DVT prophylaxis in critically ill patients requiring prolonged mechanical ventilation - A preliminary experience
Cardiology

Cardiology

Journal of Clinical & Experimental Cardiology

Author(s): Afzal Azim

Abstract Share this page

Background: Oral anticoagulants have been used for treatment and preventing recurrent thromboembolism in cardiac and orthopaedic cases. Evidence regarding the safety and efficacy of oral anticoagulants for DVT prophylaxis in critical care settings is lacking. We present, preliminary experience with acenocoumarol (acitrom) in patients requiring prolonged mechanical ventilation. Patients & Methods: 45 neurological patients requiring prolonged mechanical ventilation were included out of which only 39 could be analyzed. All underwent DVT probability risk assessment and received low molecular weight heparin along with acitrom 2mg day-1 for five days, followed by dosing adjustments until international normalized ratio (INR) of 2-3 was achieved. After achieving the INR, heparin was stopped and patients were maintained on acitrom only. Therapy was monitored with INR, bleeding complications and lower limbs Doppler. Results: Mean duration of mechanical ventilation and ICU stay was 38.57±9.23 and 47.73±16.22 days respectively. None of our patient had any complication related to acitrom therapy or any evidence of symptomatic or asymptomatic (Doppler) deep vein thrombosis during ICU stay or during follow-up of 3 months. The cost of Acitrom including the cost of INR monitoring was only 330 Indian rupees (INR) for a thirty day therapy. Conclusion: In this short case series, acitrom appears to be a suitable alternative to other available therapies for the prevention of DVT atleast in this particular subgroup of critically ill patients. However due to the small sample size we feel that a larger randomized trial is needed to come to a definite conclusion.

  • To read the full article Visit
  • DOI:
  • Subscription
This article was published in J AnaesthClinPharmacol and referenced in Journal of Clinical & Experimental Cardiology

Relevant Expert PPTs

Relevant Speaker PPTs

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords